Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Clonal Identity and Differences in Primary Cutaneous B-Cell Lymphoma Occurring at Different Sites or Time Points in the Same Patient

Fujiwara, Mika, MD*; Morales, Anjali V., MD, PhD; Seo, Katie, MS*; Kim, Youn H., MD; Arber, Daniel A., MD*; Sundram, Uma N., MD, PhD*,†

The American Journal of Dermatopathology: February 2013 - Volume 35 - Issue 1 - p 11–18
doi: 10.1097/DAD.0b013e318255dbae
Original Study
Buy

Abstract: Primary cutaneous B-cell lymphomas (PCBCL) are rare. Marginal zone lymphomas and follicle center lymphomas (FCL) represent a majority of these cases, and a significant number of cases present with multiple lesions. It is unclear whether multiple lesions in PCBCL represent dissemination of a single clone or multiple new primary lymphomas. In the current study, we analyzed paired samples from 20 PCBCL patients at more than 1 site (16) or at the same site at different time points (4) and 12 patients with benign lymphoid infiltrates to investigate for the presence or absence of a clone, and if present, whether the clones were identical. Both IGH@ and IGK@ rearrangements were tested using the BIOMED-2 protocol. We identified a clone (IGH@ and/or IGK@) in 19 of 20 (95%) PCBCL patients and 2 of 12 (17%) benign lymphoid infiltrate patients. The B-cell clones were proven to be identical in 11 of 20 (55%) PCBCL patients, including 7 of 16(44%) biopsies from patients with 2 different sites and 4 of 4 biopsies (100%) from patients at the same site but different time points. In 4 cases (3 FCL and 1 marginal zone lymphoma), different clones were detected at different sites, suggesting the possibility of a second simultaneous primary lymphoma. Our results indicate that the presence of identical clones is highly suggestive of lymphoma. To our knowledge, this is the first report to investigate the detection of identical clones in 2 distinct biopsies in PCBCL patients. Although the study is small and the results need to be confirmed in a larger study, these findings suggest that a subset of PCBCL at different sites may represent different primary tumors rather than occurrence of a single disease.

Departments of *Pathology

Dermatology, Stanford University Medical Center, Stanford, CA.

Reprints: Uma N. Sundram, MD, PhD, Department of Pathology, 300 Pasteur Drive, Room H2110, Stanford, CA 94305-5324 (e-mail: sundram@stanford.edu).

Supported by the Department of Pathology, Stanford University, Stanford, CA.

The authors declare no conflicts of interest.

© 2013 by Lippincott Williams & Wilkins.